Surgalign Holdings Stock Net Asset
| SRGADelisted Stock | USD 0.04 0 12.54% |
Surgalign Holdings fundamentals help investors to digest information that contributes to Surgalign Holdings' financial success or failures. It also enables traders to predict the movement of Surgalign Stock. The fundamental analysis module provides a way to measure Surgalign Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgalign Holdings stock.
Surgalign |
Surgalign Holdings Company Net Asset Analysis
Surgalign Holdings' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Surgalign Holdings Net Asset | 70.24 M |
Most of Surgalign Holdings' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgalign Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Surgalign Holdings has a Net Asset of 70.24 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Surgalign Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgalign Holdings' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgalign Holdings could also be used in its relative valuation, which is a method of valuing Surgalign Holdings by comparing valuation metrics of similar companies.Surgalign Holdings is currently under evaluation in net asset category among its peers.
Surgalign Fundamentals
| Return On Equity | -14.97 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (0.68) % | |||
| Current Valuation | (7.93 M) | |||
| Shares Outstanding | 9.18 M | |||
| Shares Owned By Insiders | 17.15 % | |||
| Shares Owned By Institutions | 23.05 % | |||
| Number Of Shares Shorted | 65.91 K | |||
| Price To Book | 1.79 X | |||
| Price To Sales | 0.25 X | |||
| Revenue | 81.98 M | |||
| Gross Profit | 40.29 M | |||
| EBITDA | (68.28 M) | |||
| Net Income | (54.6 M) | |||
| Cash And Equivalents | 29.34 M | |||
| Cash Per Share | 4.35 X | |||
| Total Debt | 10.19 M | |||
| Debt To Equity | 0.54 % | |||
| Current Ratio | 2.33 X | |||
| Book Value Per Share | (2.08) X | |||
| Cash Flow From Operations | (52.11 M) | |||
| Short Ratio | 0.77 X | |||
| Earnings Per Share | (8.12) X | |||
| Price To Earnings To Growth | (0.02) X | |||
| Target Price | 2.25 | |||
| Number Of Employees | 217 | |||
| Beta | 1.8 | |||
| Market Capitalization | 1.68 M | |||
| Total Asset | 70.24 M | |||
| Retained Earnings | (624.22 M) | |||
| Working Capital | 35.56 M | |||
| Z Score | -13.78 | |||
| Net Asset | 70.24 M |
About Surgalign Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgalign Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgalign Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgalign Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Surgalign Stock
If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |